Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy

NCT04463641 is registered in ClinicalTrials.gov with MicroPort CRM as lead sponsor.

NCT NCT04463641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04463641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
Lead sponsor
MicroPort CRM
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 3, 2020
Completion date
December 31, 2027
Enrollment
92 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac resynchronization therapy, heart failure